Phenelzine
Back to searchMolecule Structure
Scientific Name
Phenelzine
Description of the Drug
Phenelzine is a monoamine oxidase inhibitor used to treat atypical, nonendogenous, or neurotic depression.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00780
http://www.drugbank.ca/drugs/DB00780
Brand Name(s)
Not Available
Company Owner(s)
Parke Davis Div Warner Lambert Co, Novel Laboratories Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Monoamine oxidase | PROTEIN FAMILY | INHIBITOR | CHEMBL2095205 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34335 | |||
PharmGKB | PA450903 | |||
Human Metabolome Database | HMDB0014918 | |||
DrugBank | DB00780 | |||
PubChem: Thomson Pharma | 15297289 | |||
PubChem | 3675 | |||
Mcule | MCULE-2911295500 | |||
LINCS | LSM-5928 | |||
Nikkaji | J4.125D | |||
BindingDB | 50105417 | |||
EPA CompTox Dashboard | DTXSID2041094 | |||
DrugCentral | 2123 | |||
Brenda | 5601 | 108164 | 7268 | 31012 |
ChemicalBook | CB0434063 | |||
Guide to Pharmacology | 7266 | |||
rxnorm | PHENELZINE | PHENELZINE SULFATE | NARDIL | |
KEGG Ligand | C07430 | |||
ChEBI | 8060 | |||
ZINC | ZINC000019166991 |